Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 26,174 | 26,589 | 33,282 | 14,110 | 16,835 |
| Cost of Goods | 1,484 | 2,316 | 1,763 | 1,442 | 518 |
| Gross Profit | 24,690 | 24,273 | 31,519 | 12,668 | 16,317 |
| Operating Expenses | 30,707 | 28,480 | 33,823 | 29,093 | 25,773 |
| Operating Income | -5,533 | -3,891 | -1,541 | -15,983 | -8,938 |
| Interest Expense | 116 | 0 | 39 | 0 | 0 |
| Other Income | 70 | 77 | 96 | 204 | 143 |
| Pre-tax Income | -5,579 | -3,814 | -1,484 | -15,779 | -8,795 |
| Income Tax | -99 | -112 | 11 | 1 | 9 |
| Net Income Continuous | -5,480 | -3,702 | -1,495 | -15,780 | -8,804 |
| Net Income | $-5,480 | $-3,702 | $-1,495 | $-15,780 | $-8,804 |
| EPS Basic Total Ops | -0.40 | -0.24 | -0.12 | -1.12 | -0.64 |
| EPS Basic Continuous Ops | -0.39 | -0.26 | -0.11 | -1.13 | -0.63 |
| EPS Diluted Total Ops | -0.40 | -0.24 | -0.12 | -1.12 | -0.64 |
| EPS Diluted Continuous Ops | -0.39 | -0.26 | -0.11 | -1.13 | -0.63 |
| EBITDA(a) | $-4,326 | $-2,671 | $-673 | $-15,417 | $-8,700 |